Lucane Pharma Limited
06469424
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2025
small
Next accounts due
30/09/2027
Confirmation statement
Last: 11/11/2025
Due 25/11/2026
Industry
Officers
director · Since 20/10/2017
MANAGING DIRECTOR
DUTCH · NETHERLANDS · Age 58
Persons with Significant Control
Michael Van Woensel
Dutch · Netherlands · Age 61
6th Floor, Manfield House,, 1 Southampton Street, London, WC2R 0LR
Notified 11/01/2019
Former PSCs
Lucane Pharma Societe Par Actions Simplifee
Ceased 11/01/2019
CompanyRankvs 1681+ SIC 72110 peers47
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£2k
Balance sheet strength
Cash
£26k
Cash in the bank
Net Current Assets
-£146k
Working capital
Current Assets
—
Current Liabilities
£172k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | — | +£0 |
| 2025 | — | +£0 |
| 2024 | — | +£0 |
| 2023 | — | +£0 |
| 2022 | — | +£0 |
| 2021 | — | +£0 |
| 2020 | 0.06 | +£0 |
Derived from filed accounts. Not audited figures.